Stock listing
Yd Bio Limited
Selected listing: YDES · NASDAQ · USD · US
Yd Bio Limited (NASDAQ:YDES), Health Technology. Latest release Oct 6, 2026: YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment.
- Ticker
- NASDAQ:YDES
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
About Yd Bio Limited
The company is focused on the biotechnology sector, aiming to develop innovative solutions in healthcare. Yd Bio Limited is committed to advancing its research and product offerings to meet the needs of the market.
Latest news from Yd Bio Limited
YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
October 5, 2026
YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment
October 6, 2026
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
August 31, 2026
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research
August 4, 2026
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
July 27, 2026